PATH vs DBX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

PATH

40.0
AI Score
VS
DBX Wins

DBX

49.9
AI Score

Investment Advisor Scores

PATH

40score
Recommendation
SELL

DBX

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PATH DBX Winner
Forward P/E 17.3913 10.7296 DBX
PEG Ratio 0.4971 26.8178 PATH
Revenue Growth 13.4% 0.9% PATH
Earnings Growth 2280.8% -6.7% PATH
Tradestie Score 40.0/100 49.9/100 DBX
Profit Margin 21.0% 17.5% PATH
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD DBX

Relative Price Performance (Last 90 Days)

PATH 1M: -9.9% · 3M: +29.1% DBX 1M: +5.7% · 3M: +31.8%

Current Technical Phase

PATH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.8 · Price: $13.75

DBX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.4% over 20 days), RSI 58

RSI (14): 58.2 · Price: $35.56

Fundamentals Snapshot

Metric PATH DBX
Market Cap
Forward P/E 18.0 10.7
Trailing P/E 20.1 19.2
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.8%
Operating Margin 0.1% 0.3%
EPS 0.69 1.83
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DBX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.